
Intuitive Surgical ISRG
Annual report 2025
added 02-03-2026
Country |
|
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
357 M |
Market Cap[1] |
$ 169 B |
EBITDA (LTM) |
$ 2.67 B |
P/E (LTM) |
65.12 |
P/S (LTM) |
18.52 |
EPS (LTM) |
7.36 |
Intuitive Surgical is an American company that designs and manufactures surgical robots and related software. The company was founded in 1995 and is headquartered in Santa Clara, California.
Intuitive Surgical is a leader in the field of surgical robotics and provides its products in more than 60 countries around the world. Its main product, the Da Vinci system, allows surgeons to perform complex surgeries with high precision and minimal impact on the patient's body.
The company actively invests in research and development of new technologies to improve its products and expand its range. It also provides training and support for surgeons using its systems.
Intuitive Surgical adheres to high standards of quality and safety, and strives to improve the accessibility of its products to more patients around the world. The company continues to grow and develop to remain a leader in the field of surgical robotics and help people worldwide.
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 29.85 | 1.05 % | $ 1.43 B | Nasdaq Global Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.6 | -1.03 % | $ 433 M | Nasdaq Global Select Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 0.47 | -4.15 % | $ 19.9 M | Nasdaq Global Market | ||
|
Alcon
ALC
|
$ 77.32 | -1.5 % | $ 40.4 B | NYSE | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
ICU Medical
ICUI
|
$ 125.85 | -2.28 % | $ 3.1 B | Nasdaq Global Select Market,SPB | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.31 | -0.85 % | $ 192 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 113.0 | -1.46 % | $ 3.62 B | Nasdaq Global Select Market,SPB | ||
|
The Cooper Companies
COO
|
$ 69.92 | -2.24 % | $ 13.9 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 97.02 | -0.79 % | $ 4.7 B | NYSE,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 159.36 | -0.17 % | $ 45.8 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 59.92 | 0.72 % | $ 3.02 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 6.14 | -3.0 % | $ 33.9 K | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 175.49 | -0.01 % | $ 9.35 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 11.56 | -2.12 % | $ 28 M | Nasdaq Capital Market | ||
|
Repro Med Systems
KRMD
|
$ 4.28 | -0.7 % | $ 198 M | Nasdaq Capital Market | ||
|
Baxter International
BAX
|
$ 17.4 | -3.36 % | $ 8.93 B | NYSE,SPB | ||
|
BioLife Solutions
BLFS
|
$ 18.36 | 1.16 % | $ 846 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 3.5 | -7.89 % | $ 36.4 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 230.84 | -0.68 % | $ 33.7 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.71 | 2.62 % | $ 21.3 M | NYSE American | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 69.95 | 2.61 % | $ 4.14 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 24.61 | -3.26 % | $ 4.13 B | NYSE | ||
|
STAAR Surgical Company
STAA
|
$ 18.84 | 2.45 % | $ 934 M | Nasdaq Global Market,SPB | ||
|
Stereotaxis
STXS
|
$ 1.89 | 0.27 % | $ 172 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 107.32 | -0.87 % | $ 4.79 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 2.97 | -3.88 % | $ 218 M | Nasdaq Global Select Market,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 108.06 | 1.43 % | $ 2.45 B | Nasdaq Global Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 63.28 | 1.02 % | $ 230 M | Nasdaq Global Select Market | ||
|
Pro-Dex
PDEX
|
$ 48.46 | 3.5 % | $ 159 M | Nasdaq Global Select Market | ||
|
Microbot Medical
MBOT
|
$ 2.69 | -1.47 % | $ 27.4 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 235.46 | 1.89 % | $ 17 B | NYSE,SPB | ||
|
Repligen Corporation
RGEN
|
$ 114.2 | 0.39 % | $ 6.36 M | Nasdaq Global Select Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.54 | -2.2 % | $ 2.3 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 21.57 | 1.27 % | $ 1.45 B | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 214.57 | 1.05 % | $ 21.2 B | NYSE,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | -3.75 % | $ 22.3 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.